Review: taking Loratadine and Losartan together


Summary

Drug interactions are reported among people who take Loratadine and Losartan together. This review analyzes the effectiveness and drug interactions between Loratadine and Losartan. It is created by eHealthMe based on reports of 770 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Loratadine and Losartan >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Loratadine

Loratadine has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Loratadine 12,984 users)

Losartan

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. (latest outcomes from Losartan 25,155 users)

On Aug, 26, 2016

770 people who take Loratadine, Losartan are studied.


Number of reports submitted per year:

Loratadine and Losartan drug interactions.

Drug effectiveness over time:

Loratadine:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 16.0% - (1 of 6 people)
  • 2 - 5 years: 37.0% - (3 of 8 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 40.0% - (2 of 5 people)
  • not specified: 0.0% - (0 of 0 people)
Losartan:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 70.0% - (7 of 10 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Loratadine:
  • female: 46.0% - (7 of 15 people)
  • male: 21.0% - (3 of 14 people)
Losartan:
  • female: 56.0% - (9 of 16 people)
  • male: 53.0% - (7 of 13 people)

Drug effectiveness by age:

Loratadine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 36.0% - (4 of 11 people)
  • 60+: 36.0% - (4 of 11 people)
Losartan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 80.0% - (4 of 5 people)
  • 50-59: 60.0% - (6 of 10 people)
  • 60+: 41.0% - (5 of 12 people)

Most common drug interactions over time *:

< 1 month:
  • acidosis
  • multi-organ failure
  • neutropenia
  • respiratory failure
  • sepsis
  • thrombocytopenia
  • chest pain
  • hypertension
  • blood lactate dehydrogenase increased
  • contusion
1 - 6 months:
  • blood lactate dehydrogenase increased
  • contusion
  • grand mal convulsion
  • heel pain
  • hepatic function abnormal
  • infection
  • muscle spasms
  • prothrombin level increased
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
6 - 12 months:
  • anxiety
  • diabetes mellitus
  • hepatitis c
  • hepatotoxicity
  • pain
  • abdominal bloating
  • abdominal pain upper
  • hepatitis a
  • blood pressure increased
  • delayed ejaculation
1 - 2 years:
  • acid reflux
  • allergies
  • gouty arthritis
  • high blood pressure
  • short-term memory loss
  • back pain
  • bone and joint pain
  • cardiopulmonary failure
  • dizziness
  • forgetfulness
2 - 5 years:
  • angiopathy
  • anxiety
  • blood cholesterol increased
  • blood magnesium decreased
  • blood potassium decreased
  • blood sodium decreased
  • bone metabolism disorder
  • bursitis
  • carpal tunnel syndrome
  • cataract
5 - 10 years:
  • ed
  • embolic stroke
  • gastrointestinal haemorrhage
  • headache
  • increased tendency to bruise
  • heel pain
  • anaemia
  • bone and joint pain
  • cerebral infarction
  • diplopia
10+ years:
  • ed
  • fatigue
  • increased tendency to bruise
  • leukocytosis
  • tremor
not specified:
  • fatigue
  • cough
  • anxiety
  • dyspnoea
  • nausea
  • oedema peripheral
  • depression
  • dizziness
  • pain
  • hypertension

Most common drug interactions by gender *:

female:
  • anxiety
  • depression
  • oedema peripheral
  • fatigue
  • cough
  • urinary tract infection
  • dyspnoea
  • fall
  • nausea
  • pain
male:
  • chest pain
  • drug ineffective
  • fatigue
  • dizziness
  • myalgia
  • renal failure acute
  • cough
  • myocardial infarction
  • blood pressure increased
  • dyspnoea

Most common drug interactions by age *:

0-1:
  • rhabdomyolysis
10-19:
  • drug ineffective
  • malaise
  • urinary tract infection
  • amnesia
  • asthma
  • blood magnesium decreased
  • blood potassium decreased
  • cardiopulmonary failure
  • chest pain
  • device dislocation
20-29:
  • nausea
  • decreased appetite
  • injection site pain
  • injection site rash
  • abnormal behaviour
  • blood glucose decreased
  • blood glucose increased
  • colitis
  • petit mal epilepsy
  • psychotic disorder
30-39:
  • myalgia
  • gastrooesophageal reflux disease
  • alanine aminotransferase increased
  • anhedonia
  • anxiety
  • apnoea
  • aspartate aminotransferase increased
  • asthenia
  • balance disorder
  • blood glucose decreased
40-49:
  • hepatic neoplasm malignant
  • nausea
  • urinary tract infection
  • dizziness
  • cough
  • dehydration
  • hypotension
  • sepsis
  • vomiting
  • dyspnoea
50-59:
  • oedema peripheral
  • anxiety
  • depression
  • pain
  • drug ineffective
  • emotional distress
  • arthralgia
  • atrial fibrillation
  • fatigue
  • cardiac failure congestive
60+:
  • diarrhoea
  • dyspnoea
  • dizziness
  • insomnia
  • fatigue
  • constipation
  • fall
  • chest pain
  • oedema peripheral
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Loratadine and Losartan?

Can you answer these questions?

More questions for: Loratadine, Losartan

You may be interested in these reviews

More reviews for: Loratadine, Losartan

On eHealthMe, Loratadine (loratadine) is often used to treat hypersensitivity. Losartan (losartan potassium) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.